VDR and obesity disorder: It has been demonstrated that the intracellular concentrations of 1,25(OH)2D3 can play an important role in either promoting or inhibiting adipogenesis (which may be a target for modulation in the treatment of obesity) via the VDR and transcriptional pathways that it targets [28].